A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain

Cell Transplantation

Volumn 26, Issue 4, 2017, Pages 571-583

  Wu, Kuo Jen ^a   Yu, Seong Jin ^a   Shia, Kak Shan ^a   Wu, Chien Huang ^a   Song, Jen Shin ^a   Kuan, Hsuan Hao ^a   Yeh, Kai Chia ^a   Chen, Chiung Tong ^a   Bae, Eunkyune ^a   Wang, Yun ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

C X C chemokine receptor type 4 (CXCR4); Inflammation; Protection; Stroke

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CX 549; INTERLEUKIN 6; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CX549 COMPOUND; HETEROCYCLIC COMPOUND; NEUROPROTECTIVE AGENT; QUINAZOLINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DAMAGE; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CELL TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; MALE; MICROGLIA; MONONUCLEAR CELL; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT; STEM CELL MOBILIZATION; STROKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN INFARCTION; CHEMOTAXIS; HEK293 CELLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; INTERLEUKIN-6; MALE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; QUINAZOLINES; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; STROKE; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85017574589     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368916X693563     Document Type: Article

References (31)

1. Lipfert J, Odemis V, Wagner DC, Boltze J, Engele J. CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia. Neuropathol Appl Neurobiol. 2013;39(6):667–80.
2. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, Wang Y, Zhang C, Chopp M. Stromal cell-derived factor 1α mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab. 2006;26(1):125–34.
3. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hollt V, Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci. 2002;22(14):5865–78.
4. Tran PB, Banisadr G, Ren D, Chenn A, Miller RJ. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J Comp Neurol. 2007;500(6):1007–33.
5. Liu P, Xiang JW, Jin SX. Serum CXCL12 levels are associated with stroke severity and lesion volumes in stroke patients. Neurol Res. 2015;37(10):853–8.
6. Chen Y, Lu B, Wang J, Chen S, Lin Z, Ma X, Liu Y, Zhao B, Chen Y. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: Predictive role in ischemic stroke patients. J Stroke Cerebrovasc Dis. 2015;24(2):319–26.
7. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, Maeda M, Fagan SC, Carroll JE, Conway SJ. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: Association with bone marrow cell homing to injury. J Neuropathol Exp Neurol. 2004;63(1): 84–96.
8. Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008;1195:104–12.
9. Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology. Prog Neurobiol. 2008;84(2): 116–31.
10. Walter HL, van der Maten G, Antunes AR, Wieloch T, Ruscher K. Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke. J Neuroinflammation 2015;12:24.
11. Huang J, Li Y, Tang Y, Tang G, Yang GY, Wang Y. CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 2013;44(1):190–7.
12. Ruscher K, Kuric E, Liu Y, Walter HL, Issazadeh-Navikas S, Englund E, Wieloch T. Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab. 2013;33(8):1225–34.
13. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106(6):1901–10.
14. Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, Che Y, Ou L, Liu L, Kong D. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2011;2(10):845–54.
15. De Clerq E. The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol. 2009;77(11):1655–64.
16. Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin’s lymphoma. J Clin Oncol. 2004;22(6):1095–102.
17. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S, Hangoc G, Bridger GJ, Henson GW, Calandra G, Dale DC. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003;102(8):2728–30.
18. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders. Prog Neurobiol. 2011;95(2):213–28.
19. Chen JR, Cheng GY, Sheu CC, Tseng GF, Wang TJ, Huang YS. Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. J Anat. 2008;213(3):249–58.
20. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci. 2009;16(1):12–20.
21. Skvortsova VI, Gubskiy LV, Tairova RT, Povarova OV, Cheglakov IB, Holodenko RV, Holodenko IV, Yarygin KN, Yarygin VN. Use of bone marrow mesenchymal (stromal) stem cells in experimental ischemic stroke in rats. Bull Exp Biol Med. 2008;145(1):122–8.
22. Wu CH, Song JS, Chang KH, Jan JJ, Chen CT, Chou MC, Yeh KC, Wong YC, Tseng CT, Wu SH, Yeh CF, Huang CY, Wang MH, Sadani AA, Chang CP, Cheng CY, Tsou LK, Shia KS. Stem cell mobilizers targeting chemokine receptor CXCR4: Renoprotective application in acute kidney injury. J Med Chem. 2015;58(5):2315–25.
23. Luo Y, Zhao X, Zhou X, Ji W, Zhang L, Luo T, Liu H, Huang T, Jiang T, Li Y. Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction. Acta Biochim Biophys Sin. (Shanghai) 2013;45(7):561–9.
24. Bang OY, Jin KS, Hwang MN, Kang HY, Kim BJ, Lee SJ, Kang S, Hwang YK, Ahn JS, Sung KW. The effect of CXCR4 overexpression on mesenchymal stem cell transplantation in ischemic stroke. Cell Med. 2012;4(2):65–76.
25. Cui X, Chen J, Zacharek A, Li Y, Roberts C, Kapke A, Savant-Bhonsale S, Chopp M. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke. Stem Cells 2007;25(11):2777–85.
26. Luo Y, Kuo CC, Shen H, Chou J, Greig NH, Hoffer BJ, Wang Y. Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol. 2009;65(5):520–30.
27. Borlongan CV, Hida H, Nishino H. Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery. Neuroreport 1998;9(16):3615–21.
28. Chang CF, Morales M, Chou J, Chen HL, Hoffer BJ, Wang Y. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology 2002;43(3):418–26.
29. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 1986;17(3):472–6.
30. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci. 1997;17(11):4341–8.
31. Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, Brunner S, Vanchev Y, Fischer R, Grobner M, Huber B, Wollenweber T, Assmann G, Mueller-Hoecker J, Hacker M, Franz WM. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. Stem Cell Res. 2011;7(3):244–55.